ÅëÇÕ°Ë»ö
ä¿ëÁ¤º¸
ÇìµåÇåÆÃ
ÀÎÀçÁ¤º¸
Ä¿¹Â´ÏƼ
Àαâ°Ë»ö¾î
:
¿µ¾÷
¸¶ÄÉÆÃ
ÀÓ»ó
¿¬±¸
Ç°Áú°ü¸®
ÀλçÃѹ«
»ý»êÁ÷
¾à»ç
ÀÎÇã°¡
°£È£»ç
"Ç°Áú°ü¸®"
¿¡ ´ëÇÑ °Ë»ö °á°ú
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ - [Sanofi/»ç³ëÇÇ] Clinical Study Unit Quality Lead (CSU QL)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ | 5³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ - [Sanofi/»ç³ëÇÇ] Clinical Study Unit Quality Lead (CSU QL)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ | 5³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ - [Sanofi/»ç³ëÇÇ] Clinical Study Unit Quality Lead (CSU QL)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ | 5³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ - [Sanofi/»ç³ëÇÇ] Clinical Study Unit Quality Lead (CSU QL)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ | 5³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ - [Sanofi/»ç³ëÇÇ] Clinical Study Unit Quality Lead (CSU QL)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ | 5³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ - [Sanofi/»ç³ëÇÇ] Clinical Study Unit Quality Lead (CSU QL)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ | 5³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
¹ÙÀÌ¿ÂÆÑÁÖ½Äȸ»ç - »ý»ê ¹× Ç°Áú°ü¸® ä¿ë
¼¼Á¾½Ã ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ | 1³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
³ëÀ» ÁÖ½Äȸ»ç - °³¹ß QA
°æ±â ¿ëÀνà | ´ëÇÐ(4³â) Á¹¾÷ | 2³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
nicomedical - ÇÔ²² ÇÒ ÀǾà¿ÜÇ° Ç°Áú°ü¸® ´ã´çÀÚ ¸ðÁýÇÕ´Ï´Ù.
°æ±â ±¤Áֽà | ´ëÇÐ(4³â) Á¹¾÷ | 2³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ - [Sanofi/»ç³ëÇÇ] Quality Associate / fixed term until 2021.07.30
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ | 3³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ - [Sanofi/»ç³ëÇÇ] Quality Associate / fixed term until 2021.07.30
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ | 3³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ - [Sanofi/»ç³ëÇÇ] Quality Associate / fixed term until 2021.07.30
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ | 3³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ - [Sanofi/»ç³ëÇÇ] Quality Associate
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ | 3³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
´õºíÀ¯¸ÞµðÄ®(W-medical) - [±Þ±¸] ÀÇ·á±â±â Ç°ÁúÃ¥ÀÓÀÚ Á¤±ÔÁ÷ ä¿ë (°æ·Â)
°æ±â ³²¾çÁֽà | °íµîÇб³ | 1³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ - [Sanofi/»ç³ëÇÇ] Quality Associate
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ | 3³â
¡è
| ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
11
12
13
14
15
16
17
18
19
20
½Ç½Ã°£ Àα⠰˻ö¾î
CR
GE
cra
regulatory
gmp
¸¶ÄÉÆÃ
am
¾à»ç
1
Ç°Áú°ü¸®
4
ÀÓ»ó
1
°³ÀÎÁ¤º¸Ã³¸®¹æħ
|
ȸ¿ø¾à°ü
|
°í°´Áö¿ø¼¾ÅÍ
|
Á¦ÈÞ ¹× ±¤°í¹®ÀÇ
|
´ÙÀÌ·ºÆ®°áÁ¦
¼³¸³ÀÏ : 2015³â 12¿ù 02ÀÏ l °³ÀÎÁ¤º¸Ã¥ÀÓÀÚ : À±º´È£
Á÷¾÷Á¤º¸Á¦°ø»ç¾÷½Å°í¹øÈ£ J150002023003
»ç¾÷ÀÚµî·Ï¹øÈ£ : 285-18-01963
| Åë½ÅÆǸž÷½Å°í : Á¦ 2023-ÀÎõ-0450È£
Copyright ¨Ï
Æĸ¶¸ÞµðÀâ
Co. Ltd. All rights reserved.